0.5418

4.16% +0.0217

Bluejay Diagnostics Inc (BJDX)

Overview News Price History Financials Why BJDX Down? Discussions Forecast Stock Split

Bluejay Diagnostics Inc stock is currently priced at $0.5418, with a 24-hour trading volume of 4,915. It has seen a +4.16% increased in the last 24 hours and a -15.35% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.5348 pivot point. If it approaches the $0.5691 resistance level, significant changes may occur.

Previous Close:

$0.5201

Open:

$0.5119

24h Volume:

4,915

Market Cap:

$1.42M

Revenue:

Net Income/Loss:

$-10.04M

P/E Ratio:

-0.0514

EPS:

-10.55

Net Cash Flow:

$-9.34M

1W Performance:

+1.07%

1M Performance:

-15.35%

6M Performance:

-83.63%

1Y Performance:

+69.93%

1D Range:

$0.502

$0.5599

52W Range:

$0.19

$13.98

Bluejay Diagnostics Inc Stock (BJDX) Company Profile

Name

Bluejay Diagnostics Inc

Sector

Healthcare (1223)

Industry

Medical Devices (160)

Phone

844 327 7078

Address

360 Massachusetts Avenue, Suite 203, Acton

Employee

Twitter

Next Earnings Date

Latest SEC Filings

BJDX's Discussions on Twitter

Bluejay Diagnostics Inc Stock (BJDX) Latest News

Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

Benzinga

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

GlobeNewswire Inc.

Gold Moves Lower; US Crude Stocks Decline Last Week

Benzinga

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Crude Oil Down 1%; US Wholesale Inventories Fall In November

Benzinga

Dow Gains 50 Points; US Jobless Claims Rise To 218,000

Benzinga

Bluejay Diagnostics Inc Stock (BJDX) Financials Data

Bluejay Diagnostics Inc (BJDX) Net Income 2024

BJDX net income (TTM) was -$10.04 million for the quarter ending September 30, 2023, a -19.90% decrease year-over-year.

Bluejay Diagnostics Inc (BJDX) Cash Flow 2024

BJDX recorded a free cash flow (TTM) of -$9.34 million for the quarter ending September 30, 2023, a -12.48% decrease year-over-year.

Bluejay Diagnostics Inc (BJDX) Earnings per Share 2024

BJDX earnings per share (TTM) was -$9.57 for the quarter ending September 30, 2023, a -14.03% decline year-over-year.

Bluejay Diagnostics Inc Stock (BJDX) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Dey Svetlana	Director	Dec 13 '23	Buy	3.07	500	1,535	1,500

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.